南方医科大学学报 ›› 2025, Vol. 45 ›› Issue (7): 1554-1562.doi: 10.12122/j.issn.1673-4254.2025.07.23
收稿日期:
2025-04-03
出版日期:
2025-07-20
发布日期:
2025-07-17
通讯作者:
赵克,王晓东
E-mail:liuyitong@stu2021.jnu.edu.cn;zhaoke@mail.sysu.edu.cn;wangxd33@mail.sysu.edu.cn
作者简介:
刘倚彤,在读本科生,E-mail: liuyitong@stu2021.jnu.edu.cn
基金资助:
Yitong LIU1(), Ke ZHAO2,3(
), Xiaodong WANG2,3(
)
Received:
2025-04-03
Online:
2025-07-20
Published:
2025-07-17
Contact:
Ke ZHAO, Xiaodong WANG
E-mail:liuyitong@stu2021.jnu.edu.cn;zhaoke@mail.sysu.edu.cn;wangxd33@mail.sysu.edu.cn
摘要:
目的 系统分析1990~2021年东亚地区唇与口腔癌的疾病负担现状、变化趋势以及未来情况。 方法 本研究利用全球疾病负担2021数据库,对中国(含中国台湾省)、日本、韩国、朝鲜和蒙古的疾病负担数据,按照年龄、性别及主要危险因素进行了分层,并采用贝叶斯年龄-时期-队列模型预测未来趋势。 结果 1990~2021年,东亚地区唇与口腔癌的疾病负担呈逐步上升趋势。中国台湾省的发病率、患病率、死亡率以及伤残调整生命年(DALYs)均出现最大增幅,而蒙古的死亡率和DALYs则出现下降。2021年,中国台湾省的唇与口腔癌发病率(27.50/10万人)、患病率(137.92/10万人)、死亡率(9.59/10万人)以及DALYs(292.07人年/10万人)均为最高,尤其在男性及老年人群体中尤为突出。烟草和酒精消费加剧了中国台湾省和日本的疾病负担。未来预测显示,中国(不含中国台湾省)的发病率和患病率将继续上升,而除中国台湾省和朝鲜外,其他地区的死亡率预计将有所下降。 结论 东亚地区唇与口腔癌的疾病负担持续增加,尤其在中国台湾省。为了应对这一挑战,亟需采取有效措施控制主要危险因素,推动早期筛查的普及,以及实现医疗资源的公平分配。
刘倚彤, 赵克, 王晓东. 1990~2035年东亚地区唇与口腔癌的疾病负担分析及未来预测[J]. 南方医科大学学报, 2025, 45(7): 1554-1562.
Yitong LIU, Ke ZHAO, Xiaodong WANG. Lip and oral cancers in East Asia from 1990 to 2035: trends of disease burden and future projections[J]. Journal of Southern Medical University, 2025, 45(7): 1554-1562.
Region | China (excluding Taiwan Province of China) | Taiwan Province of China | Japan | Mongolia | Republic of Korea | Democratic People's Republic of Korea |
---|---|---|---|---|---|---|
Incidence (per 100 000) (95%UI) | ||||||
1990 | 1.25 (1.05, 1.44) | 5.07 (4.65, 5.46) | 4.15 (3.93, 4.32) | 3.85 (2.74, 5.30) | 4.08 (3.50, 4.80) | 1.45 (1.05, 2.01) |
2021 | 3.96 (3.18, 4.91) | 27.50 (24.57, 30.71) | 11.92 (10.34, 13.14) | 5.44 (3.89, 7.20) | 19.94 (15.59, 24.44) | 2.48 (1.73, 3.36) |
TRC | 2.17 (1.35, 3.18) | 4.42 (3.76, 5.20) | 1.87 (1.57, 2.10) | 0.41 (-0.08, 1.16) | 3.89 (2.64, 5.23) | 0.71 (0.12, 1.54) |
Prevalence (per 100 000) (95%UI) | ||||||
1990 | 3.40 (2.86, 3.94) | 23.18 (21.19, 25.08) | 15.05 (14.38, 15.67) | 1.71 (1.21, 2.35) | 1.40 (1.21, 1.63) | 4.78 (3.40, 6.64) |
2021 | 15.12 (12.1, 18.57) | 137.92 (123.15, 154.58) | 38.2 (34.07, 41.39) | 1.82 (1.29, 2.42) | 5.21 (4.07, 6.35) | 8.71 (6.09, 12.05) |
TRC | 3.45 (2.32, 4.80) | 4.95 (4.22, 5.85) | 1.54 (1.31, 1.73) | 0.06 (-0.30, 0.63) | 2.72 (1.80, 3.64) | 0.82 (0.15, 1.77) |
Mortality (per 100 000) (95%UI) | ||||||
1990 | 0.84 (0.71, 0.96) | 2.11 (1.95, 2.28) | 1.31 (1.24, 1.35) | 1.39 (0.98, 1.92) | 0.67 (0.59, 0.77) | 0.88 (0.64, 1.19) |
2021 | 1.68 (1.33, 2.09) | 9.59 (8.63, 10.61) | 3.98 (3.3, 4.36) | 1.22 (0.85, 1.62) | 1.46 (1.15, 1.75) | 1.39 (0.97, 1.87) |
TRC | 1.00 (0.50, 1.64) | 3.54 (3.00, 4.18) | 2.04 (1.67, 2.26) | -0.12 (-0.42, 0.36) | 1.18 (0.65, 1.67) | 0.57 (0.04, 1.38) |
DALYs (per 100 000) (95%UI) | ||||||
1990 | 25.11 (21.05, 29.10) | 71.85 (65.87, 77.38) | 34.35 (33.07, 35.28) | 41.48 (29.49, 57.14) | 20.92 (18.40, 24.24) | 27.84 (19.96, 38.5) |
2021 | 43.44 (34.27, 54.63) | 292.07 (262.97, 324.45) | 69.09 (60.94, 73.92) | 38.41 (27.28, 51.27) | 34.45 (26.63, 41.54) | 40.29 (27.55, 55.84) |
TRC | 0.73 (0.28, 1.30) | 3.07 (2.58, 3.65) | 1.01 (0.84, 1.12) | -0.07 (-0.38, 0.44) | 0.65 (0.23, 1.03) | 0.45 (-0.07, 1.20) |
表1 东亚地区唇癌和口腔癌的发病率、患病率、死亡率以及DALYs
Tab.1 The incidence, prevalence, mortality and disability-adjusted life years (DALYs) of lip and oral cancer in East Asia
Region | China (excluding Taiwan Province of China) | Taiwan Province of China | Japan | Mongolia | Republic of Korea | Democratic People's Republic of Korea |
---|---|---|---|---|---|---|
Incidence (per 100 000) (95%UI) | ||||||
1990 | 1.25 (1.05, 1.44) | 5.07 (4.65, 5.46) | 4.15 (3.93, 4.32) | 3.85 (2.74, 5.30) | 4.08 (3.50, 4.80) | 1.45 (1.05, 2.01) |
2021 | 3.96 (3.18, 4.91) | 27.50 (24.57, 30.71) | 11.92 (10.34, 13.14) | 5.44 (3.89, 7.20) | 19.94 (15.59, 24.44) | 2.48 (1.73, 3.36) |
TRC | 2.17 (1.35, 3.18) | 4.42 (3.76, 5.20) | 1.87 (1.57, 2.10) | 0.41 (-0.08, 1.16) | 3.89 (2.64, 5.23) | 0.71 (0.12, 1.54) |
Prevalence (per 100 000) (95%UI) | ||||||
1990 | 3.40 (2.86, 3.94) | 23.18 (21.19, 25.08) | 15.05 (14.38, 15.67) | 1.71 (1.21, 2.35) | 1.40 (1.21, 1.63) | 4.78 (3.40, 6.64) |
2021 | 15.12 (12.1, 18.57) | 137.92 (123.15, 154.58) | 38.2 (34.07, 41.39) | 1.82 (1.29, 2.42) | 5.21 (4.07, 6.35) | 8.71 (6.09, 12.05) |
TRC | 3.45 (2.32, 4.80) | 4.95 (4.22, 5.85) | 1.54 (1.31, 1.73) | 0.06 (-0.30, 0.63) | 2.72 (1.80, 3.64) | 0.82 (0.15, 1.77) |
Mortality (per 100 000) (95%UI) | ||||||
1990 | 0.84 (0.71, 0.96) | 2.11 (1.95, 2.28) | 1.31 (1.24, 1.35) | 1.39 (0.98, 1.92) | 0.67 (0.59, 0.77) | 0.88 (0.64, 1.19) |
2021 | 1.68 (1.33, 2.09) | 9.59 (8.63, 10.61) | 3.98 (3.3, 4.36) | 1.22 (0.85, 1.62) | 1.46 (1.15, 1.75) | 1.39 (0.97, 1.87) |
TRC | 1.00 (0.50, 1.64) | 3.54 (3.00, 4.18) | 2.04 (1.67, 2.26) | -0.12 (-0.42, 0.36) | 1.18 (0.65, 1.67) | 0.57 (0.04, 1.38) |
DALYs (per 100 000) (95%UI) | ||||||
1990 | 25.11 (21.05, 29.10) | 71.85 (65.87, 77.38) | 34.35 (33.07, 35.28) | 41.48 (29.49, 57.14) | 20.92 (18.40, 24.24) | 27.84 (19.96, 38.5) |
2021 | 43.44 (34.27, 54.63) | 292.07 (262.97, 324.45) | 69.09 (60.94, 73.92) | 38.41 (27.28, 51.27) | 34.45 (26.63, 41.54) | 40.29 (27.55, 55.84) |
TRC | 0.73 (0.28, 1.30) | 3.07 (2.58, 3.65) | 1.01 (0.84, 1.12) | -0.07 (-0.38, 0.44) | 0.65 (0.23, 1.03) | 0.45 (-0.07, 1.20) |
图5 1990~2021年东亚地区唇癌和口腔癌的流行趋势以及2021~2035年的预测
Fig.5 Prevalence trends of lip and oral cancer in East Asia from 1990 to 2021 and projections from 2021 to 2035. A-F: Incidences in China (excluding Taiwan Province of China), Taiwan Province of China, Japan, Republic of Korea, Democratic People's Republic of Korea, and Mongolia, respectively; G-L: Prevalence in China (excluding Taiwan Province of China), Taiwan Province of China, Japan, Republic of Korea, Democratic People's Republic of Korea, and Mongolia, respectively.
[1] | G B D 2019 Lip O, da Cunha AR, Compton K,et al. The global, regional, and national burden of adult lip, oral, and pharyngeal cancer in 204 countries and territories: a systematic analysis for the global burden of disease study 2019[J]. JAMA Oncol, 2023, 9(10): 1401-16. |
[2] | Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-49. doi:10.3322/caac.21660 |
[3] | Su SY, Chen WT, Chiang CJ, et al. Oral cancer incidence rates from 1997 to 2016 among men in Taiwan: Association between birth cohort trends and betel nut consumption[J]. Oral Oncol, 2020, 107: 104798. doi:10.1016/j.oraloncology.2020.104798 |
[4] | Su MJ, Ho CH, Yeh CC. Association of alcohol consumption, betel nut chewing, and cigarette smoking with mortality in patients with head and neck cancer among the Taiwanese population: a nationwide population-based cohort study[J]. Cancer Epidemiol, 2024, 89: 102526. doi:10.1016/j.canep.2024.102526 |
[5] | Jian XC, Jian Y, Wu XS, et al. Oral submucous fibrosis transforming into squamous cell carcinoma: a prospective study over 31 years in mainland China[J]. Clin Oral Investig, 2021, 25(4): 2249-56. doi:10.1007/s00784-020-03541-9 |
[6] | Sunguc C, Hawkins MM, Winter DL, et al. Risk of subsequent primary oral cancer in a cohort of 69, 460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study[J]. Br J Cancer, 2023, 128(1): 80-90. doi:10.1038/s41416-022-02016-w |
[7] | Yang YY, Ning H, Liang BH, et al. Exploring factors influencing patient delay behavior in oral cancer: the development of a risk prediction model in western China[J]. Healthcare (Basel), 2024, 12(22): 2252. doi:10.3390/healthcare12222252 |
[8] | Ng SW, Syamim Syed Mohd Sobri SN, Zain RB, et al. Barriers to early detection and management of oral cancer in the Asia Pacific region[J]. J Health Serv Res Policy, 2022, 27(2): 133-40. doi:10.1177/13558196211053110 |
[9] | Tatokoro M, Matsuo N. The impact of aging on symptom prevalence and management in terminally ill patients with cancer[J]. J Pain Symptom Manage, 2022, 63(2): 251-9. doi:10.1016/j.jpainsymman.2021.09.001 |
[10] | Hu YN, Zhong R, Li HY, et al. Effects of betel quid, smoking and alcohol on oral cancer risk: a case-control study in Hunan Province, China[J]. Subst Use Misuse, 2020, 55(9): 1501-8. doi:10.1080/10826084.2020.1750031 |
[11] | Yang YH, Warnakulasuriya S, Yang HF, et al. Public health measures to reduce Areca nut and betel quid use for control of oral cancer in Taiwan[J]. Oral Oncol, 2020, 108: 104915. doi:10.1016/j.oraloncology.2020.104915 |
[12] | Kim YT, Kang MJ, Lee BA, et al. Risk factors and incidence of oral tumors: Findings from a longitudinal population-based study[J]. Oral Dis, 2025, 31(3): 846-56. doi:10.1111/odi.15125 |
[13] | Liu BW, Shen MX, Xiong JM, et al. Synergistic effects of betel quid chewing, tobacco use (in the form of cigarette smoking), and alcohol consumption on the risk of malignant transformation of oral submucous fibrosis (OSF): a case-control study in Hunan Province, China[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2015, 120(3): 337-45. doi:10.1016/j.oooo.2015.04.013 |
[14] | Hu YJ, Chen J, Zhong WS, et al. Trend analysis of betel nut-associated oral cancer and health burden in China[J]. Chin J Dent Res, 2017, 20(2): 69-78. |
[15] | Pinheiro LC, Reshetnyak E, Akinyemiju T, et al. Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study[J]. Cancer, 2022, 128(1): 122-30. doi:10.1002/cncr.33894 |
[16] | Zaitsu T, Saito T, Kawaguchi Y. The oral healthcare system in Japan[J]. Healthcare (Basel), 2018, 6(3): 79. doi:10.3390/healthcare6030079 |
[17] | Rai P, Ng A, Intekhab I, et al. Oral cancer in Asia - a systematic review[J]. Adv Oral Maxillofac Surg, 2022, 8: 100366. doi:10.1016/j.adoms.2022.100366 |
[18] | Nagao T, Warnakulasuriya S. Screening for oral cancer: Future prospects, research and policy development for Asia[J]. Oral Oncol, 2020, 105: 104632. doi:10.1016/j.oraloncology.2020.104632 |
[19] | GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440): 2133-61. |
[20] | GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440): 2162-203. |
[21] | Warnakulasuriya S, Chen TH. Areca nut and oral cancer: evidence from studies conducted in humans[J]. J Dent Res, 2022, 101(10): 1139-46. doi:10.1177/00220345221092751 |
[22] | Yang YH. Oral cancer in Taiwan[J]. Oral Dis, 2025, 31(5): 1455-66. doi:10.1111/odi.15076 |
[23] | Chuang SL, Su WW, Chen SL, et al. Population-based screening program for reducing oral cancer mortality in 2, 334, 299 Taiwanese cigarette smokers and/or betel quid chewers[J]. Cancer, 2017, 123(9): 1597-609. doi:10.1002/cncr.30517 |
[24] | Zhang XY, Xie WH, Ye H, et al. Mortality and disease burden of oral cancer in China: a time-trend analysis on the China Death Surveillance Database from 2006 to 2021[J]. BMC Oral Health, 2024, 24(1): 938. doi:10.1186/s12903-024-04717-5 |
[25] | Badarch J, Batbaatar S, Paulik E. Prevalence and correlates of poor oral hygiene among school-going students in Mongolia[J]. Dent J (Basel), 2021, 9(2): 12. doi:10.3390/dj9020012 |
[26] | Webster J, Santos JA, Hogendorf M, et al. Implementing effective salt reduction programs and policies in low- and middle-income countries: learning from retrospective policy analysis in Argentina, Mongolia, South Africa and Vietnam[J]. Public Health Nutr, 2022, 25(3): 805-16. doi:10.1017/s136898002100344x |
[27] | Chimed-Ochir O, Delgermaa V, Takahashi K, et al. Mongolia health situation: based on the global burden of disease study 2019[J]. BMC Public Health, 2022, 22(1): 5. doi:10.1186/s12889-021-12070-3 |
[28] | Zhang JY, Lu YB, Li HR, et al. Lip and oral cavity cancer burden and related risk factors in China: estimates and forecasts from 1990 to 2049[J]. Healthcare (Basel), 2022, 10(9): 1611. doi:10.3390/healthcare10091611 |
[29] | Saraswat N, Pillay R, Everett B, et al. Knowledge, attitudes and practices of South Asian immigrants in developed countries regarding oral cancer: an integrative review[J]. BMC Cancer, 2020, 20(1): 477. doi:10.1186/s12885-020-06944-9 |
[30] | Yu ZR, Ma XM, Xiao HY, et al. Disease burden and attributable risk factors of lip and oral cavity cancer in China from 1990 to 2021 and its prediction to 2031[J]. Front Public Health, 2024, 12: 1419428. doi:10.3389/fpubh.2024.1419428 |
[31] | Ghanem AS, Memon HA, Nagy AC. Evolving trends in oral cancer burden in Europe: a systematic review[J]. Front Oncol, 2024, 14: 1444326. doi:10.3389/fonc.2024.1444326 |
[32] | Lenoci D, Moresco E, Cavalieri S, et al. Oral cancer in young adults: incidence, risk factors, prognosis, and molecular biomarkers[J]. Front Oncol, 2024, 14: 1452909. doi:10.3389/fonc.2024.1452909 |
[33] | Montégut L, López-Otín C, Kroemer G. Aging and cancer[J]. Mol Cancer, 2024, 23(1): 106. doi:10.1186/s12943-024-02020-z |
[34] | Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression[J]. Nat Rev Cancer, 2020, 20(2): 89-106. doi:10.1038/s41568-019-0222-9 |
[35] | Matsuda Y, Jayasinghe RD, Zhong H, et al. Oral health management and rehabilitation for patients with oral cancer: a narrative review[J]. Healthcare (Basel), 2022, 10(5): 960. doi:10.3390/healthcare10050960 |
[36] | Sanna M, Gao W, Chiu YW, et al. Tobacco control within and beyond WHO MPOWER: outcomes from Taiwan SimSmoke[J]. Tob Control, 2020, 29(1): 36-42. doi:10.1136/tobaccocontrol-2018-054544 |
[37] | Chen RH, Chang HY, Hsu YT, et al. Harm from others' drinking among young adults in Taiwan: Predictors and deteriorating quality of life[J]. Drug Alcohol Rev, 2024, 43(6): 1483-92. doi:10.1111/dar.13903 |
[38] | Flor LS, Reitsma MB, Gupta V, et al. The effects of tobacco control policies on global smoking prevalence[J]. Nat Med, 2021, 27(2): 239-43. doi:10.1038/s41591-020-01210-8 |
[39] | Tamil Selvan S, Yeo XX, van der Eijk Y. Which countries are ready for a tobacco endgame A scoping review and cluster analysis[J]. Lancet Glob Health, 2024, 12(6): e1049-58. doi:10.1016/s2214-109x(24)00085-8 |
[1] | 吕雪彩, 刘艳红, 韩诗怡, 张浩赟, 侯爱生, 周志康, 史立凯, 高洁, 曹江北, 张宏, 米卫东. 老年患者胃肠道手术后综合并发症的危险因素——一项多中心观察性研究[J]. 南方医科大学学报, 2025, 45(4): 736-743. |
[2] | 周勇, 吴媛, 曾汇文, 陈翠梅, 谢群, 贺莉萍. 艰难梭菌的感染特征及其危险因素:基于中南地区某市住院腹泻患者的标本[J]. 南方医科大学学报, 2024, 44(5): 998-1003. |
[3] | 戈 悦, 李建伟, 梁宏开, 侯六生, 左六二, 陈 珍, 卢剑海, 赵 新, 梁静漪, 彭 岚, 包静娜, 段佳欣, 刘 俐, 毛可晴, 曾振华, 胡鸿彬, 陈仲清. VA-ECMO患者院内死亡风险预测模型的构建及验证:一项多中心、回顾性、病例对照研究[J]. 南方医科大学学报, 2024, 44(3): 491-498. |
[4] | 胡嘉伟, 杜芳, 丁璐, 王路翔, 赵巍峰. 合并高血压病的乙型肝炎肝硬化患者发生肝细胞癌的风险评估:一项基于倾向性匹配评分的回顾性队列研究[J]. 南方医科大学学报, 2024, 44(11): 2243-2249. |
[5] | 蔡涛浓, 卢江丽, 林志君, 罗明睿, 梁海滔, 秦自科, 叶云林. 单中心非肌层浸润性膀胱癌患者行卡介苗灌注治疗的疗效分析[J]. 南方医科大学学报, 2023, 43(3): 488-494. |
[6] | 张浩轩, 陆 进, 蒋成义, 方美芳. 基于人工智能技术的鼻咽癌风险预测模型的构建与评价[J]. 南方医科大学学报, 2023, 43(2): 271-279. |
[7] | 唐 巧, 周 超, 张 宁, 何召云, 张晶晶, 付双楠, 李 昕, 刘鹏程, 张田义, 张 瑾, 宫 嫚. 肝硬化可疑自发性细菌性腹膜炎患者的预后及发生死亡的危险因素[J]. 南方医科大学学报, 2023, 43(12): 2043-2052. |
[8] | 张小凤, 杨 子, 胡秋子, 左芦根, 宋 雪, 耿志军, 李 静, 王月月, 葛思堂, 胡建国. CENPU在结直肠癌组织中高表达并对患者的远期预后有评估价值[J]. 南方医科大学学报, 2022, 42(8): 1198-1204. |
[9] | 李晴晴, 邱权威, 张乐乐, 张小凤, 王月月, 耿志军, 葛思堂, 左芦根, 宋 雪, 李 静, 胡建国. ALDH3B1的表达与肿瘤组织病理学和远期预后相关[J]. 南方医科大学学报, 2022, 42(5): 633-640. |
[10] | 何爱萍, 丁心怡, 黄佳利, 罗祥蓉, 孟健夫, 曹 瑛, 高 方, 邹梦晨. 糖尿病足溃疡合并下肢动脉病变的临床特点及相关危险因素[J]. 南方医科大学学报, 2022, 42(4): 604-609. |
[11] | 邓 亚, 王春艳, 付懿铭, 李忠斌, 纪 冬. 慢性药物性肝损伤的复发风险与肝纤维化程度高度相关[J]. 南方医科大学学报, 2022, 42(11): 1655-1661. |
[12] | 翟跃芬, 王虎清, 展淑琴, 吴海琴. 静脉溶栓治疗急性重度脑梗死的疗效及预后的不良相关危险因素:152例随机对照临床试验[J]. 南方医科大学学报, 2021, 41(9): 1426-1430. |
[13] | 周萌萌, 陈金东, 王 昊, 席斯祺, 甘 田, 赵 亮. 低CHA2DS2-VASc评分的非瓣膜性心房颤动患者的心房血栓形成的独立危险因素[J]. 南方医科大学学报, 2021, 41(8): 1243-1249. |
[14] | 唐翠萍, 陈飞龙, 郑松塬, 吴利生, 陈世贤, 朱俊卿, 李 娟. 强直性脊柱炎患者减停TNF-α抑制剂后的复发情况及预测因素:52周前瞻性临床随访[J]. 南方医科大学学报, 2021, 41(5): 633-639. |
[15] | 申磊磊, 云天洋, 郭俊唐, 刘 阳, 梁朝阳. 左侧非小细胞肺癌4L组淋巴结转移的临床病理学特征及危险因素分析[J]. 南方医科大学学报, 2020, 40(12): 1793-1798. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||